137 related articles for article (PubMed ID: 29568235)
21. Omega-3 fatty acid protects cardiomyocytes against hypoxia-induced injury through targeting MiR-210-3p/CASP8AP2 axis.
Yu X; Liu F; Liu Y; Bai B; Yin H; Wang H; Feng Y; Ma H; Geng Q
Mol Cell Biochem; 2021 Aug; 476(8):2999-3007. PubMed ID: 33791918
[TBL] [Abstract][Full Text] [Related]
22. E2f3a and E2f3b contribute to the control of cell proliferation and mouse development.
Chong JL; Tsai SY; Sharma N; Opavsky R; Price R; Wu L; Fernandez SA; Leone G
Mol Cell Biol; 2009 Jan; 29(2):414-24. PubMed ID: 19015245
[TBL] [Abstract][Full Text] [Related]
23. E2f3a and E2f3b make overlapping but different contributions to total E2f3 activity.
Danielian PS; Friesenhahn LB; Faust AM; West JC; Caron AM; Bronson RT; Lees JA
Oncogene; 2008 Nov; 27(51):6561-70. PubMed ID: 18663357
[TBL] [Abstract][Full Text] [Related]
24. Effect of microRNA-210 on prognosis and response to chemotherapeutic drugs in pediatric acute lymphoblastic leukemia.
Mei Y; Gao C; Wang K; Cui L; Li W; Zhao X; Liu F; Wu M; Deng G; Ding W; Jia H; Li Z
Cancer Sci; 2014 Apr; 105(4):463-72. PubMed ID: 24720529
[TBL] [Abstract][Full Text] [Related]
25. Regulation of transcription factor E2F3a and its clinical relevance in ovarian cancer.
Reimer D; Hubalek M; Kiefel H; Riedle S; Skvortsov S; Erdel M; Hofstetter G; Concin N; Fiegl H; Müller-Holzner E; Marth C; Altevogt P; Zeimet AG
Oncogene; 2011 Sep; 30(38):4038-49. PubMed ID: 21516127
[TBL] [Abstract][Full Text] [Related]
26. Systems-wide RNAi analysis of CASP8AP2/FLASH shows transcriptional deregulation of the replication-dependent histone genes and extensive effects on the transcriptome of colorectal cancer cells.
Hummon AB; Pitt JJ; Camps J; Emons G; Skube SB; Huppi K; Jones TL; Beissbarth T; Kramer F; Grade M; Difilippantonio MJ; Ried T; Caplen NJ
Mol Cancer; 2012 Jan; 11():1. PubMed ID: 22216762
[TBL] [Abstract][Full Text] [Related]
27. Targeted Casp8AP2 methylation increases drug resistance in mesenchymal stem cells and cancer cells.
Lee KD; Pai MY; Hsu CC; Chen CC; Chen YL; Chu PY; Lee CH; Chen LT; Chang JY; Huang TH; Hsiao SH; Leu YW
Biochem Biophys Res Commun; 2012 Jun; 422(4):578-85. PubMed ID: 22595458
[TBL] [Abstract][Full Text] [Related]
28. E2F3a is critically involved in epidermal growth factor receptor-directed proliferation in ovarian cancer.
Reimer D; Hubalek M; Riedle S; Skvortsov S; Erdel M; Concin N; Fiegl H; Müller-Holzner E; Marth C; Illmensee K; Altevogt P; Zeimet AG
Cancer Res; 2010 Jun; 70(11):4613-23. PubMed ID: 20460525
[TBL] [Abstract][Full Text] [Related]
29. Up-regulated miR-155 is associated with poor prognosis in childhood acute lymphoblastic leukemia and promotes cell proliferation targeting ZNF238.
Liang C; Li Y; Wang LN; Zhang XL; Luo JS; Peng CJ; Tang WY; Huang LB; Tang YL; Luo XQ
Hematology; 2021 Dec; 26(1):16-25. PubMed ID: 33357126
[TBL] [Abstract][Full Text] [Related]
30. CREBBP knockdown enhances RAS/RAF/MEK/ERK signaling in Ras pathway mutated acute lymphoblastic leukemia but does not modulate chemotherapeutic response.
Dixon ZA; Nicholson L; Zeppetzauer M; Matheson E; Sinclair P; Harrison CJ; Irving JA
Haematologica; 2017 Apr; 102(4):736-745. PubMed ID: 27979926
[TBL] [Abstract][Full Text] [Related]
31. Knockdown of E2F3 Inhibits Proliferation, Migration, and Invasion and Increases Apoptosis in Glioma Cells.
Shen ZG; Liu XZ; Chen CX; Lu JM
Oncol Res; 2017 Nov; 25(9):1555-1566. PubMed ID: 28337965
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of E2F5/p130, but not E2F5 alone, can inhibit E2F-induced cell cycle entry in transgenic mice.
Chen Q; Liang D; Overbeek PA
Mol Vis; 2008 Mar; 14():602-14. PubMed ID: 18385796
[TBL] [Abstract][Full Text] [Related]
33. Up-regulated A20 promotes proliferation, regulates cell cycle progression and induces chemotherapy resistance of acute lymphoblastic leukemia cells.
Chen S; Xing H; Li S; Yu J; Li H; Liu S; Tian Z; Tang K; Rao Q; Wang M; Wang J
Leuk Res; 2015 Sep; 39(9):976-83. PubMed ID: 26159495
[TBL] [Abstract][Full Text] [Related]
34. Reduction of RUNX1 transcription factor activity by a CBFA2T3-mimicking peptide: application to B cell precursor acute lymphoblastic leukemia.
Jakobczyk H; Debaize L; Soubise B; Avner S; Rouger-Gaudichon J; Commet S; Jiang Y; Sérandour AA; Rio AG; Carroll JS; Wichmann C; Lie-A-Ling M; Lacaud G; Corcos L; Salbert G; Galibert MD; Gandemer V; Troadec MB
J Hematol Oncol; 2021 Mar; 14(1):47. PubMed ID: 33743795
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA 34b inhibits cell proliferation in pediatric acute myeloid leukemia via regulating LDHA.
Qi HX; Cao Q; Zhou GP; Sun XZ; Zhou WD; Hong Z; Hu J; Juan CX; Li S; Kuai WX
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5351-5359. PubMed ID: 31298387
[TBL] [Abstract][Full Text] [Related]
36. MDM2 induces NF-kappaB/p65 expression transcriptionally through Sp1-binding sites: a novel, p53-independent role of MDM2 in doxorubicin resistance in acute lymphoblastic leukemia.
Gu L; Findley HW; Zhou M
Blood; 2002 May; 99(9):3367-75. PubMed ID: 11964305
[TBL] [Abstract][Full Text] [Related]
37. Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells.
Rao J; Xu DR; Zheng FM; Long ZJ; Huang SS; Wu X; Zhou WH; Huang RW; Liu Q
J Transl Med; 2011 May; 9():71. PubMed ID: 21595920
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-101 regulates T-cell acute lymphoblastic leukemia progression and chemotherapeutic sensitivity by targeting Notch1.
Qian L; Zhang W; Lei B; He A; Ye L; Li X; Dong X
Oncol Rep; 2016 Nov; 36(5):2511-2516. PubMed ID: 27666896
[TBL] [Abstract][Full Text] [Related]
39. High VLA-4 expression is associated with adverse outcome and distinct gene expression changes in childhood B-cell precursor acute lymphoblastic leukemia at first relapse.
Shalapour S; Hof J; Kirschner-Schwabe R; Bastian L; Eckert C; Prada J; Henze G; von Stackelberg A; Seeger K
Haematologica; 2011 Nov; 96(11):1627-35. PubMed ID: 21828124
[TBL] [Abstract][Full Text] [Related]
40. Significance of SODD expression in childhood acute lymphoblastic leukemia and its influence on chemotherapy.
Tao HF; Liu YS; Fang JL; Su YZ; Chen FH; Zhou LY; Zhu YS
Genet Mol Res; 2014 Mar; 13(1):2020-31. PubMed ID: 24737427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]